you through our and quarter take few on as outlook. I and by a afternoon. Joe, well I as you start Thanks, first will XXXX will flow financial full our taking pages cash results, then updated through year also good
slide to seven. Turning
at is quarter. look first results Here the for our quick a
with our we year, sales, really to had fourth year. the quarter quarter a For start from strong continuing last momentum the
product rate. Medical Electrochem modest more growth but at in double-digit we saw organically, increased business, X% continue lines, growth accelerate continued while and our we to Sales in our a
QX the And prior just the year Adjusted the results was million. EBITDA quarter, impact increased comparable X% year-over-year. around to $X during at FX
both EPS Adjusted to $X.XX the and prior on the FX current FX. includes the net increased related of income Adjusted and exclude year. basis a organically XX% impact when $X.XX in was you reported year losses
to moving slide Now eight.
or X% year. million first the that about quarter EBITDA versus see can last You adjusted $X increased
we approximately million year. incentive QX year last compensation in had versus of However, $X higher this
adjusted impact, have would this XX%. increased Excluding EBITDA
net of breaking up at about down incentive I the page. impact looking that was to about million side pieces, the income $X up then adjusted adjusted last right the of adjusted Adjusted EPS. was income XX% versus the And and and net XX%. mentioned $X.XX comp on Now year is on EPS
of be be To on versus year it the be this we improved year slightly due to last compensation, first about material our clear higher but performance. expect versus incentive do in impact year, will a earnings full to last the not our half year
improvement All would about other operational be then share. $X.XX a or million $X
interest versus and last of about tax quarter from year. lower a rate benefit from $X.XX in expense the a had $X.XX also year lower We this
us Overall, about the and on really going trajectory first good we puts this forward. results our feel quarter
XXXX. of you million The Turning first into flow And our to flow. during merger back with the nine. cash will flow I performance in Lake take quarter the $XX first quarter. translated strongest free of slide generated $XX We from quarter. million this Region through the for cash since cash operations
to make our inventory went progress the almost quarter. of at up the inventory continued We turns management, end with five and to
and our our operating X.X. This of combined efficient use continue down to more flow, versus leverage balances, In with to quarter, us of to $XX further allowed in our have million significantly reduced cash addition, expenses reducing strong accelerate debt debt the other we paid cash year. the payments prior
XX. slide Turning to
payments taking the announced the from have guidance debt cash planned divestiture And flow for any and clear, up for are We impact today. is guidance we this to our excluding year. be
million, least flow million. be be $XXX from a We flow are million, least $XXX cash expecting up at and $XXX million, operations from from $XXX to now cash up to at free
million pay Xx debt and comfortably are And leverage, reduce at we of to the year. expect lastly, XXXX. our $XXX end we will of continue expecting to to the now least EBITDA be during now by down addition, In under
to we in are As continued generating as demonstrates committed deliver continuing leverage. we area. quarter sustainable and cash are flow reducing I've well continued to this operating emphasize, to this as And that
talk for Now year about like to I'd our XXXX. outlook full
our for we we EPS. flow, adjusted to lines, guidance closed divestiture we the AS&O product the cash come this our you sales, back to have will guidance increasing guidance contemplate and transaction. EBITDA not once adjusted revised once and addition of does And with for clarity, again planned are In
solid we expect momentum seeing also are the be results, XXXX year and we quarter now the growth sales to full for year. Given first and our X% X% between
$XXX X% EBITDA, have to rate approximately increased we XX%. adjusted For growth our to $XXX million range be of which a should to million,
expect million the share in For of addition and depreciation to a range to year. $XXX want be year, share. just $XX per to million to in now $X.XX and expect share, to guidance, this range other million comments. for still the adjusted $XX capital $X.XX earnings million range to in expenditures a amortization few I of And per be we to a the $XXX We in for of
expenses $XX a Stock-based million year. to significant of operating compensation spending is expected for And the as of range our be prior us. is other to million behind years expected integration be on to the which million approximately $XX in reduction $XX to from majority are the is now million, $XX acquisition
adjusted the And to range year to bit of XX% effective for the a range rate lastly, have the in we tax XX%. tightened be full
product turn transaction announced to discuss to line the on it now growth an update results, strategy and you Joe today. I give the sales back will our turn I and to then will to
tailwind Orthopedics to really see one is slide products program. and of Portable can an up driven from up as The well XX, that start as Portable Medical new was customer's implants, strong products, continued had increases as growth year. sales year-over-year the of build Sales Surgical, spinal by in part Medical continued Advanced On XX% ramping accelerating products first a the in quarter. you growth inventory
We will customer's expect at inventory business, build slower plans see year-over-year for solid as a this one that pace growth we but continue sales slow.
XX. and growth components a as C&V Vascular top continued Cardio This slide products line demand product contract The the to demand continued manufacturing and the X%. existing sales its of to strategy. has growth saw strong Turning was quarter for growth growth teams by strong strong increasing Integer-owned line execute in driven & for successfully have year-over-year
staying product this of execute the can four on to to a continues to growth product over remain on basis, the Vascular continues the you line by digits continue last consistently line rolling that solid Cardio quarters, we the single growth When & product momentum as look strong, quarter solid, see in several you and our trajectory to to we driven remain at continue offering. line see our continued accelerate Market in success strategy high this product growth.
continue product a and to to line our this we as overall that such innovate of ensure capabilities resources with developing in market focusing speed customers' faster accelerating areas, to We're goal success. our in
for Cardiac Looking positive in at increasing line, the slide product turned Sales X%. Neuromodulation & first quarter XX.
flat overall, relatively our market For seen to stabilization we CRM, remain with customers. some the continues but have
a and very that neuromodulation, strong. customers year's gain And our continued also half products In to were resolved first supply strength. impacted prior the of XXXX. sales constraint these And we
The we sales further reflects first the in return rolling growth four saw to trend quarter quarter. the
next We by to growth for in quarters, the low digit strength middle overall to single over of line expect to couple continue see neuromodulation. product the driven
for As we've line. the mentioned the our customers. before, accelerating sales focused are And the key market-leading device through a as active of remains product of medical support on long-term we driver outsourcer, neuromodulation market growth the neuromodulation
to management and full customers on development component continue with we cardiac manufacturing execute capability support Overall, design, provide enable success growth. and in to and rhythm our strategy neuro, to partnering
the Electrochem growth Now year-over-year gain growth outlook drive and XX. market team XXXX year, start business executes XX% new positive had product business solid solid to on the and energy environmental - win sales in up in continues to a and this new a Electrochem's the basis. slide to had for The continues a market, wins on had growth as remain also solid share on initiatives. to quarter the quarter. continues line
turn now to call Joe. will the I back
